Monitor for supply chain cost improvements and inventory stability in upcoming quarters; the investment suggests confidence in long-term demand but carries execution and integration risks. Watch for further updates on regulatory approval and closing timeline.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 27 $279.44entry
- T+1 · 7mo ago −4.95%α −4.46% · $265.61
- T+5 · 7mo ago +4.39%α +3.99% · $291.72
- T+20 · 6mo ago +46.61%α +41.65% · $409.68
- T+60 · 4mo ago +1.14%α −3.64% · $282.62
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
MACOM announced long-term supply agreements with IQE plc and a £45 million investment in IQE through equity and a convertible loan note. The deal aims to strengthen supply chain resilience and secure epitaxial services critical to MACOM's growth strategy, with MACOM gaining board representation in IQE.
Key Financial Metrics
Key Facts
- MACOM entered into Long-Term Supply Agreements (LTSAs) with IQE for epitaxial services across multiple technologies.
- MACOM will invest £45 million in IQE via equity and a convertible loan note.
- The investment is contingent on regulatory clearances and other customary closing conditions.
- MACOM will receive board representation at IQE as part of the transaction.
- The move is intended to enhance supply chain security and support MACOM’s long-term growth.
Financial Impact
£45 million investment (~$57.6 million at 1.28 USD/GBP), representing a strategic but non-dilutive supply chain enhancement
Risk Factors
- Regulatory approvals may delay or block the transaction.
- Execution risk in integrating supply chain operations with IQE.
- Exposure to IQE's financial performance through equity and convertible note.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3281889 |
Track record
41 reports on MTSI
7 of 12 bullish or bearish reports moved the stock their way by T+1. Best: +29.11% at T+5 after the Nov 5, 2026 report. 10 of 12 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry price pending
- Nov 13, 20263d ago Insider Cluster Neutral 3/10 Entry $231.40 Now $220.44 −4.74% settles Nov 17
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $232.06 to $220.44 Now $220.44 −5.01% ▼ −5.01% −3.10% vs SPY
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $245.76 to $232.06 Now $220.44 −10.30% ▼ −5.57% −5.21% vs SPY
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $226.48 to $249.86 Now $220.44 −2.67% ▲ +10.32% +9.00% vs SPY
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $226.48 to $249.86 Now $220.44 −2.67% ▲ +10.32% +9.00% vs SPY
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $226.48 to $249.86 Now $220.44 −2.67% ▲ +10.32% +9.00% vs SPY
- Nov 6, 202610d ago 144 Neutral 3/10 Entry $230.00 to $226.48 Now $220.44 −4.16% ▼ −1.53% −1.16% vs SPY
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $190.35 to $210.98 Now $220.44 +15.81% ▲ +10.84% +10.53% vs SPY
- Nov 5, 202611d ago 8-K Bullish 6/10 No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers